BioWorld Science

Oct. 21, 2021

View Archived Issues

FDG-PET signal is substantially affected by microglial glucose uptake in neurodegenerative diseases

Read More

New spondyloarthritis therapeutic target identified

Read More

Elevated plasma CXCL16 levels found in severe COVID-19 patients

Read More

LRFN1 gene as a possible cause of autism spectrum disorder

Read More

Discovery of broad-spectrum inhibitor of oncogenic BRAF dimerization

Read More

Role of de novo mutations in severe male infertility

Read More

Hutchison MediPharma patents new CSF1R inhibitors

Read More

Chinese researchers disclose new ROS inhibitors

Read More

Whole exome sequencing analysis identifies novel genes associated with osteoarthritis

Read More

Angiex presents new TM4SF1-targeting PROTACs

Read More

Dongguan Hec New Drug Research and Development synthesizes new HBV antivirals

Read More

Medshine Discovery describes new compounds for cancer

Read More

Alu RNA induces retinal pigment epithelium degeneration in geographic atrophy via the inflammasome

Read More

Mitochondrial augmentation: a promising disease-modifying strategy for mitochondrial DNA disorders

Read More

NPAS3 identified as a risk gene for autism spectrum disorder

Read More

Tango Therapeutics' MTAPnull PRMT5 inhibitor TNG-908 active in multiple xenograft tumor models

Read More

HLA fine mapping identifies INPP5A as a risk gene for tuberculosis

Read More

Oncodesign and TiumBio collaborate to discover and develop candidates for fibrosis

Read More

Mablink and Emergence enter licensing agreement for ADC targeting Nectin-4

Read More